Cummings JF, Polhemus ME, Kester KE, Ockenhouse CF, et al. A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults. Vaccine 2024 Apr 6:S0264-410X(24)00389-X. doi: 10.1016/j.vaccine.2024.
PMID: 38584058